Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy

Not Applicable

Completed

• Conditions: Postoperative Complications

• Registration Number: NCT01995786
• Lead Sponsor: Regina Elena Cancer Institute

Brief Summary

The aim of the study is to evaluate clinical and economic impact of Goal Directed Fluid Therapy according to NICE haemodynamic protocol. Haemodynamic parameters were assessed using automated pulse contour analysis (Flotrac/Vigileo®). A specific dedicated software has been developed to perform clinical and expenditures data collection, both retrospective and prospective data are archived.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Study First Submitted: 2013-11-21
• Study First Submitted QC: 2013-11-26
• Study First Posted: 2013-11-27
• Primary Completion: 2014-12
• Status Verified: 2016-04
• Last Update Submitted: 2016-04-06
• Last Update Posted: 2016-04-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients selected for major abdominal surgery

Exclusion Criteria

•Patients under the age of 18, patients with hemodynamically significant aortic regurgitation and heart rhythm disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
rate of reduction of postoperative spending	30 day postoperative

Trial Locations

Locations (1)

Regina Elena CI; 🇮🇹 Rome, Italy